{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:29:17Z","timestamp":1785803357945,"version":"3.56.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neuropharm.2022.109023","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:16:50Z","timestamp":1646371010000},"page":"109023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Inflammation at the crossroads of COVID-19, cognitive deficits and depression"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-7655","authenticated-orcid":false,"given":"Natalia M.","family":"Lyra e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda G.Q.","family":"Barros-Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda G.","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio T.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109023_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2022.109023_bib2","article-title":"Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients","volume":"7","author":"Alexopoulos","year":"2020","journal-title":"Neurology: Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109023_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease","volume":"28","author":"\u00c1lvarez","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2022.109023_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psyneuen.2017.07.003","article-title":"Neurotrophic and inflammatory markers in bipolar disorder: a prospective study","volume":"84","author":"van den Ameele","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-2600(21)00139-9","article-title":"Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context","volume":"9","author":"Angriman","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbi.2011.10.010","article-title":"Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms","volume":"26","author":"Aschbacher","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib7","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.04-1625fje","article-title":"Interleukin\u20106: a cytokine to forget","volume":"18","author":"Balschun","year":"2004","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.109023_bib8","first-page":"75","article-title":"Plasma beta amyloid and cytokine profile in women with Alzheimer's disease","volume":"29","author":"Baranowska-Bik","year":"2008","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.neuropharm.2022.109023_bib9","first-page":"152","article-title":"Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease","author":"Basak","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3201\/eid2609.202122","article-title":"Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020","volume":"26","author":"Benameur","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009848","article-title":"Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy","author":"Benussi","year":"2020","journal-title":"American Academy of Neurology"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109023_bib13","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/NXI.0000000000001029","article-title":"Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation","volume":"8","author":"Bernard-Valnet","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2022.109023_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neuropharm.2022.109023_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2007.10.020","article-title":"Systemic immune aberrations in Alzheimer's disease patients","volume":"193","author":"Bonotis","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"31","key":"10.1016\/j.neuropharm.2022.109023_bib16","doi-asserted-by":"crossref","first-page":"eabc5801","DOI":"10.1126\/sciadv.abc5801","article-title":"Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia COVID-19-associated anosmia","volume":"6","author":"Brann","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2022.109023_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbi.2011.10.008","article-title":"Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning","volume":"26","author":"Burton","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-021-02314-2","article-title":"The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models","volume":"141","author":"Butowt","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib19","first-page":"146","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood\u2013brain barrier","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib20","first-page":"368","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2022.109023_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01948-2020","article-title":"Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication","volume":"56","author":"Chen","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.neuropharm.2022.109023_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","article-title":"TNF\u03b1 disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice","volume":"69","author":"Cheng","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib23","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-NeuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2020.06.032","article-title":"COVID-19 and the chemical senses: supporting players take center stage","volume":"107","author":"Cooper","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109023_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib26","series-title":"The TNF\u03b1-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss","author":"Creed Pettigrew","year":"2016"},{"key":"10.1016\/j.neuropharm.2022.109023_bib27","first-page":"19","article-title":"SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability","author":"Crunfli","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.neuropharm.2022.109023_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12252-4","article-title":"Interleukin-1\u03b2 (IL-1\u03b2) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro","volume":"203","author":"Cunningham","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109023_bib29","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.02747-12","article-title":"Infiltrating macrophages are key to the development of seizures following virus infection","volume":"87","author":"Cusick","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.neuropharm.2022.109023_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome(SARS) associated coronavirus(SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1460-9568.2000.00011.x","article-title":"Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex","volume":"12","author":"D'Arcangelo","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib35","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbi.2019.08.005","article-title":"IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease","volume":"82","author":"Escrig","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijid.2020.05.123","article-title":"Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid","volume":"96","author":"Esp\u00edndola","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib39","article-title":"Inflammatory cytokine patterns associated with neurological diseases in COVID-19","author":"Esp\u00edndola","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2020.04.004","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system","author":"de Felice","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11866-7","article-title":"Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice","volume":"10","author":"Figueiredo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41419-019-1529-x","article-title":"Neonatal infection leads to increased susceptibility to A\u03b2 oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice","volume":"10","author":"Frost","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib43","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood\u2013brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib44","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41593-019-0427-y","article-title":"T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses","volume":"22","author":"Garber","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib45","article-title":"Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation","author":"Garcia","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.neuropharm.2022.109023_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-017-0568-7","article-title":"Herpes simplex encephalitis: an update","volume":"19","author":"Gnann","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.neuropharm.2022.109023_bib47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","article-title":"Sepsis-associated encephalopathy","volume":"8","author":"Gofton","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib49","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cell.2015.11.023","article-title":"Neuroinflammatory TNF\u03b1 impairs memory via astrocyte signaling","volume":"163","author":"Habbas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109023_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","article-title":"Biological basis of the behavior of sick animals","volume":"12","author":"Hart","year":"1988","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109023_bib51","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","author":"Helms","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13054-020-03200-1","article-title":"Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2022.109023_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"Hemachudha","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib56","first-page":"31","article-title":"Type I interferon receptor signaling in astrocytes regulates hippocampal synaptic plasticity and cognitive function of the healthy CNS","author":"Hosseini","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109023_bib57","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109023_bib58","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1017\/S1041610217001016","article-title":"Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort","volume":"29","author":"Johnson","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib59","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19","author":"Kanberg","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib60","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jocn.2015.02.035","article-title":"Association between sepsis and dementia","volume":"22","author":"Kao","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib61","series-title":"Neuropharmacology","first-page":"419","article-title":"Depressive-like behavior induced by tumor necrosis factor-\u03b1 in mice","author":"Kaster","year":"2012"},{"key":"10.1016\/j.neuropharm.2022.109023_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ni.3656","article-title":"Infectious immunity in the central nervous system and brain function","volume":"18","author":"Klein","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000513040","article-title":"Evidence of SARS-CoV2 entry protein ACE2 in the human nose and olfactory bulb","volume":"209","author":"Klingenstein","year":"2020","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.neuropharm.2022.109023_bib64","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib65","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/j.1460-9568.2008.06549.x","article-title":"Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide","volume":"28","author":"Konsman","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib66","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid1002.030638","article-title":"Possible central nervous system infection by SARS coronavirus","volume":"10","author":"Lau","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib68","series-title":"Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-To-Moderate Forms of the Coronavirus Disease (COVID-19): a Multicenter European Study","first-page":"1","author":"Lechien","year":"2020"},{"key":"10.1016\/j.neuropharm.2022.109023_bib69","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib70","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer's amyloid-\u03b2 oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib71","article-title":"Microvascular injury in the brains of patients with covid-19","author":"Lee","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib72","article-title":"Cerebrospinal fluid features in COVID-19 patients with neurologic manifestations: correlation with brain MRI findings in 58 patients","author":"Lersy","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(96)01283-8","article-title":"Interleukin-6 inhibits long-term potentiation in rat hippocampal slices","volume":"748","author":"Li","year":"1997","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109023_bib74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2022.109023_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109023_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-021-00249-2","article-title":"SARS-CoV-2 cell tropism and multiorgan infection","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discovery"},{"key":"10.1016\/j.neuropharm.2022.109023_bib78","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's \u03b2-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib79","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109023_bib80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease","volume":"11","author":"Lyra e Silva","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109023_bib81","doi-asserted-by":"crossref","first-page":"n908","DOI":"10.1136\/bmj.n908","article-title":"Covid-19: one in three has neurological or psychiatric condition diagnosed after covid infection, study finds","volume":"373","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2022.109023_bib82","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib83","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes simplex virus-1 in the brain: the dark side of a sneaky infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fmolb.2020.605236","article-title":"Structural characterization of SARS-CoV-2: where we are, and where we need to Be","volume":"7","author":"Mariano","year":"2020","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/j.neuropharm.2022.109023_bib85","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1073\/pnas.95.6.3251","article-title":"Sympathetic neurons can produce and respond to interleukin 6","volume":"95","author":"M\u00e4rz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2022.109023_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00059","article-title":"Astrocyte heterogeneity: impact to brain aging and disease","volume":"11","author":"Matias","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib87","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-virology-092917-043439","article-title":"Flaviviruses and the central nervous system: revisiting neuropathological concepts","volume":"5","author":"Maximova","year":"2018","journal-title":"Annual Review of Virology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2021.02.021","article-title":"Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up","author":"Mazza","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib91","series-title":"The Role of Inflammation in Depression: from Evolutionary Imperative to Modern Treatment Target","author":"Miller","year":"2015"},{"key":"10.1016\/j.neuropharm.2022.109023_bib92","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","article-title":"Inflammatory blockade restores adult hippocampal neurogenesis","volume":"302","author":"Monje","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109023_bib93","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMc1509458","article-title":"Human coronavirus OC43 associated with fatal encephalitis","volume":"375","author":"Morfopoulou","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib94","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/WNL.0000000000010640","article-title":"Long-haul COVID","volume":"95","author":"Nath","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib95","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib96","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamapsychiatry.2020.4442","article-title":"Association of psychiatric disorders with mortality among patients with COVID-19","volume":"78","author":"Nemani","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12035-016-0307-3","article-title":"Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice","volume":"55","author":"Neves","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/23744235.2020.1729403","article-title":"Infectious Diseases Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child","volume":"52","author":"Nilsson","year":"2020","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.neuropharm.2022.109023_bib99","article-title":"Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone","volume":"1\u201313","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2022.109023_bib100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12035-021-02593-6","article-title":"SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia","volume":"59","author":"Olajide","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib101","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of covid-19 in the Young","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib102","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","article-title":"Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress","volume":"163","author":"Pace","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102436","article-title":"Non-permissive SARS-CoV-2 infection in human neurospheres","volume":"54","author":"Pedrosa","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.neuropharm.2022.109023_bib104","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2009.09.023","article-title":"Viral infection leading to brain dysfunction: more prevalent than appreciated?","volume":"64","author":"van den Pol","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109023_bib106","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19\u2013associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib107","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","author":"Puelles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib108","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106230","article-title":"SARS\u2010CoV\u20102 targets neurons of 3D human brain organoids","volume":"39","author":"Ramani","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2022.109023_bib109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stemcr.2021.02.007","article-title":"Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids","volume":"16","author":"Ramani","year":"2021","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.neuropharm.2022.109023_bib110","article-title":"The S1 protein of SARS-CoV-2 crosses the blood\u2013brain barrier in mice","author":"Rhea","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109023_bib111","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/S2665-9913(20)30309-X","article-title":"Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment","volume":"2","author":"Robinson","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib112","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00415-020-10123-y","article-title":"Neurological comorbidity and severity of COVID-19","volume":"268","author":"Romagnolo","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib113","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009937","article-title":"Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry","author":"Romero-S\u00e1nchez","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2003.08.030","article-title":"A dual role for interleukin-1 in LTP in mouse hippocampal slices","volume":"144","author":"Ross","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib115","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.109023_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007873","article-title":"Human bornavirus research: back on track","volume":"15","author":"Rubbenstroth","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neuropharm.2022.109023_bib117","article-title":"Interleukin-6 receptor inhibition in covid-19 - cooling the inflammatory soup","author":"Rubin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2015.05.062","article-title":"TNF-alpha inhibition prevents cognitive decline and maintains hippocampal BDNF levels in the unpredictable chronic mild stress rat model of depression","volume":"292","author":"\u015eahin","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109023_bib119","first-page":"12","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2626-z","article-title":"Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms","volume":"23","author":"Sasannejad","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2022.109023_bib122","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder \u2014 pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib123","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.3233\/JAD-179925","article-title":"Brain inflammation connects cognitive and non-cognitive symptoms in Alzheimer's disease","volume":"64","author":"Selles","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib124","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00134-007-0598-y","article-title":"Brain lesions in septic shock: a magnetic resonance imaging study","volume":"33","author":"Sharshar","year":"2007","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2022.109023_bib126","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000000665","article-title":"Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife","volume":"83","author":"Singh-Manoux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41582-020-00453-w","article-title":"Neurological infection with SARS-CoV-2 \u2014 the story so far","volume":"17","author":"Solomon","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib128","article-title":"Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages","author":"Song","year":"2020","journal-title":"Cytometry"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109023_bib129","doi-asserted-by":"crossref","first-page":"100288","DOI":"10.1016\/j.xcrm.2021.100288","article-title":"Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms","volume":"2","author":"Song","year":"2021","journal-title":"Cell Rep Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib130","first-page":"218","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib131","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.molmed.2018.09.001","article-title":"Viral encephalitis and neurologic diseases: focus on astrocytes","volume":"24","author":"Soung","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2021.04.001","article-title":"Innate immune memory mediates increased susceptibility to Alzheime\u0155s disease-like pathology in sepsis surviving mice","author":"De Sousa","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109023_bib133","doi-asserted-by":"crossref","first-page":"eaar2749","DOI":"10.1126\/scitranslmed.aar2749","article-title":"Acute and chronic neurological consequences of early-life Zika virus infection in mice","volume":"10","author":"Souza","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109023_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020060","article-title":"Late neurological consequences of Zika virus infection: risk factors and pharmaceutical approaches","volume":"12","author":"Souza","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2022.109023_bib135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nature04671","article-title":"Synaptic scaling mediated by glial TNF-\u03b1","volume":"440","author":"Stellwagen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109023_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.120","article-title":"Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes","volume":"2","author":"Sukoff Rizzo","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109023_bib137","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.26004","article-title":"Serum neurofilament light chain levels in the intensive care unit: comparison between severely ill patients with and without Coronavirus Disease 2019","volume":"89","author":"Sutter","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib138","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib139","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib140","first-page":"1","article-title":"Dementia is an age\u2010independent risk factor for severity and death in COVID\u201019 inpatients","author":"Tahira","year":"2021","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.109023_bib141","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","article-title":"Inflammatory markers and the risk of Alzheimer disease","volume":"68","author":"Tan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib142","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0304-3940(92)90071-E","article-title":"Tumor necrosis factor alters synaptic transmission in rat hippocampal slices","volume":"146","author":"Tancredi","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109023_bib143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109023_bib145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib146","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab148","article-title":"COVID-19 neuropathology at columbia university irving medical center\/New York presbyterian hospital","author":"Thakur","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2022.109023_bib147","first-page":"113","article-title":"Neurological manifestations in severe acute respiratory syndrome","volume":"14","author":"Tsai","year":"2005","journal-title":"Acta Neurol. Taiwan"},{"key":"10.1016\/j.neuropharm.2022.109023_bib148","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese encephalitis \u2014 the prospects for new treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib149","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1126\/scisignal.aao4910","article-title":"Structural principles of tumor necrosis factor superfamily signaling","volume":"11","author":"Vanamee","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2022.109023_bib150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature18283","article-title":"A complement\u2013microglial axis drives synapse loss during virus-induced memory impairment","volume":"534","author":"Vasek","year":"2016","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.neuropharm.2022.109023_bib151","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/ene.14703","article-title":"Biomarkers for CNS injury in CSF are elevated in COVID\u201019 and associated with neurological symptoms and disease severity","author":"Virhammar","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib152","article-title":"How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109023_bib153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2022.109023_bib154","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.neuropharm.2022.109023_bib155","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.109023_bib156","article-title":"Solidarity trial plus: an international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care","author":"World Health Organization","year":"2021","journal-title":"ISRCTN"},{"key":"10.1016\/j.neuropharm.2022.109023_bib157","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109023_bib158","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/cns.13257","article-title":"Microglia\/macrophage diversities in central nervous system physiology and pathology","volume":"25","author":"Xie","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2022.109023_bib159","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/444461","article-title":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis","volume":"41","author":"Xu","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109023_bib160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.neuropharm.2022.109023_bib161","first-page":"1","article-title":"Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China","volume":"1","author":"Zeng","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2022.109023_bib162","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41422-020-0390-x","article-title":"SARS-CoV-2 infects human neural progenitor cells and brain organoids","volume":"30","author":"Zhang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2022.109023_bib163","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2022.109023_bib164","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib165","first-page":"E1","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","author":"Zubair","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2022.109023_bib166","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J. Psychiatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:17:51Z","timestamp":1758439071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082200082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":165,"alternative-id":["S002839082200082X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109023","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation at the crossroads of COVID-19, cognitive deficits and depression","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109023"}}